HIF1A and breast carcinoma: However, in breast cancer cells, we found that miR-101 can target and down-regulate VHL expression, which is a negative regulator of hypoxia-inducible factor 1 subunit alpha (HIF1α) to increase HIF-1α expression and HIF-1α downstream target VEGFA expression.